Classifications: anthelmintic; Therapeutic: anthelmintic; antiparasitic
Pregnancy Category: C
3 mg tablets
A semisynthetic anthelmintic agent which is a broad-spectrum antiparasitic agent with a unique mode of action. It leads to
an increase in permeability to chloride ions of the cell membrane of the parasites, resulting in hyperpolarization of nerve
or muscle cells of parasites. Hyperpolarization of nerve and muscle cells of parasites results in their paralysis and cell
Causes cell death of parasites.
Treatment of strongyloidiasis of the intestinal tract, onchocerciasis.
Hypersensitivity to ivermectin; pregnancy (category C). Safety and efficacy in children weighing ≤15
kg are not established.
Asthma; older adults; moderate or severe hepatic disease.
Route & Dosage
Adult/Child (≥15 kg): PO 200 mcg/kg x 1 dose
Adult/Child (≥15 kg): PO 150 mcg/kg x 1 dose, may repeat q312 mo prn
- Give tablets with water rather than any other type of liquid.
- Store below 30° C (86° F).
Adverse Effects (≥1%)Body as a Whole: Fever,
peripheral edema. CNS:
Tachycardia. GI: Diarrhea
, nausea. Skin: Pruritus, rash. Other:
4 h. Distribution:
Distributed into breast milk. Metabolism:
In the liver. Elimination:
In feces over 12 d. Half-Life:
Assessment & Drug Effects
- Monitor for therapeutic effectiveness: Indicated by negative stool samples.
- Monitor for cardiovascular effects such as orthostatic hypotension and tachycardia.
- Monitor for and report inflammatory conditions of the eyes.
Patient & Family Education
- Get a follow-up stool examination to determine effectiveness of treatment. Treatment for worms does not kill adult parasites;
repeated follow-up and retreatment are usually needed.
- Notify physician if eye discomfort develops.